Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Nicotine Replacement Product

Approved

JJohns Hopkins University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Tobacco DependenceActive, not recruiting

Tobacco DependenceApproved

Active, not recruiting

Timeline

Expected Milestones

Q2 2027

ApprovedActive, not recruiting

Tobacco Dependence

NCT07220356

Clinical

Trials by Indication[1]

Tobacco Dependence1 trial

C-Raven: Pilot RCT of an Avatar-delivered Computerized Intervention for Tobacco Cessation With Community Health Worker Linkage to Lung Cancer Screening in Baltimore City (FY26)

Active, not recruiting·JJohns Hopkins University·Approved·NCT07220356·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Nicotine Replacement Product. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Nicotine Replacement Product. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Johns Hopkins University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Approved[1]
Company: JJohns Hopkins University

Related News